Richard Freer Sample Contracts

SEC Documents
Filings
Personal financials
Insider transactions
Previous Companies
director, 10 percent owner, officer: Chief Executive Officer until April 12th, 2013
Commonwealth Biotechnologies Inc – Commonwealth Biotechnologies, Inc. Enters Into Agreement to Sell the Assets of its CBI Services and Fairfax Identity Laboratories Divisions (July 22nd, 2009)

Commonwealth Biotechnologies, Inc. (“CBI”) (NASDAQ Capital Market:CBTE) is pleased to announce that an agreement has been signed with Bostwick Laboratories, Inc. (“Bostwick”) for the sale of the assets of CBI’s Fairfax Identity Laboratories (“FIL”) and CBI Services divisions. Bostwick has agreed to purchase such assets for a purchase price of $1,075,000.00, in cash and certain royalty payments to the CBI over a five-year period. In addition, CBI will lease to Bostwick, the building located at 601 Biotech Drive, Richmond Virginia housing the CBI Services and Fairfax Identity Laboratories. Subject to Bostwick’s satisfaction of its two week due diligence inspection and approval of the sale by CBI’s shareholders and lenders, the sale is expected to close in the third fiscal quarter of 2009.

Commonwealth Biotechnologies Inc – Commonwealth Biotechnologies, Inc. Reaches Agreement on Extending Convertible Notes. (July 14th, 2009)

Commonwealth Biotechnologies, Inc. (“CBI”) (NASDAQ Capital Market:CBTE) is pleased to announce that it has reached an agreement with its PIPE investors to extend for 6 months its convertible note facilities of approximately $1.4M that matured on June 30 and has also received consent to suspend the financial covenants under such note facilities through the 3rd Quarter.

Commonwealth Biotechnologies Inc – Commonwealth Biotechnologies, Inc. Announces Signing of Stock Purchase Agreement to Acquire Mimotopes Pty Ltd Acquisition seen as the initial step in a strategic re-positioning of the company aimed at driving growth and increasing shareholder value (November 29th, 2006)

RICHMOND, VIRGINIA (November 27, 2006) – Commonwealth Biotechnologies, Inc. (“CBI”) (Nasdaq Capital Market: CBTE), a life sciences contract research organization and biotechnology company, announced today that the Board of Directors of CBI has unanimously approved and the company has executed a Stock Purchase Agreement to acquire all of the outstanding capital stock of Mimotopes Pty Ltd (“Mimotopes”). Mimotopes, which is based in Melbourne, Australia, is a wholly-owned subsidiary of PharmAust Chemistry Ltd. (“Chemistry”). Chemistry, in turn, is a wholly-owned subsidiary of PharmAust Limited (“PAA”), a company traded on the Australia Stock Exchange. As consideration for the transaction, CBI will issue 2,150,000 shares of CBI common stock to Chemistry. As a result, PAA, through Chemistry, will hold a 39.5% equity position in CBI. CBI has obtained an initial, independent, third party fairness opinion of this transaction, which deemed the transaction to be fair from a financial point of vi

Commonwealth Biotechnologies Inc – Commonwealth Biotechnologies, Inc. Modifies and Extends Term Sheet to Acquire Mimotopes Pty Ltd (October 3rd, 2006)

RICHMOND, VIRGINIA (October 2, 2006) – Commonwealth Biotechnologies, Inc. (Nasdaq Capital Market: CBTE), a life sciences contract research organization and biotechnology company, announced today that it has signed a modified and extended non-binding term sheet (the “Term Sheet”) to acquire the outstanding capital stock of Mimotopes Pty Ltd (“Mimotopes”), a wholly-owned subsidiary of PharmAust Ltd, an Australian Stock Exchange listed company (ASX: PAA), in a transaction structure yet to be formally determined.

Commonwealth Biotechnologies Inc – TERMS SHEET COMMONWEALTH BIOTECHNOLOGIES INC AND PHARMAUST LTD September 29, 2006 (October 3rd, 2006)
Commonwealth Biotechnologies Inc – Commonwealth Biotechnologies, Inc. Signs Term Sheet to Acquire Mimotopes Pty Ltd (July 26th, 2006)

RICHMOND, VIRGINIA (July 26, 2006) – Commonwealth Biotechnologies, Inc. (Nasdaq Capital Market: CBTE), a life sciences contract research organization and biotechnology company, announced today that it has signed a non-binding term sheet (the “Term Sheet”) to acquire the outstanding capital stock of Mimotopes Pty Ltd (“Mimotopes”), a wholly-owned subsidiary of PharmAust Ltd, an Australian Stock Exchange listed company (ASX: PAA), in a transaction structure yet to be formally determined.

Commonwealth Biotechnologies Inc – WARRANT TO PURCHASE SHARES (September 26th, 2002)
Commonwealth Biotechnologies Inc – 1997 STOCK INCENTIVE PLAN (October 7th, 1997)
Commonwealth Biotechnologies Inc – EMPLOYMENT AGREEMENT (October 7th, 1997)
Commonwealth Biotechnologies Inc – EXECUTIVE SEVERANCE AGREEMENT (October 7th, 1997)
Commonwealth Biotechnologies Inc – WARRANT AGREEMENT (October 7th, 1997)
Commonwealth Biotechnologies Inc – EMPLOYMENT AGREEMENT (October 7th, 1997)
Commonwealth Biotechnologies Inc – EMPLOYMENT AGREEMENT (October 7th, 1997)
Commonwealth Biotechnologies Inc – EMPLOYMENT AGREEMENT (July 21st, 1997)
Commonwealth Biotechnologies Inc – EXECUTIVE SEVERANCE AGREEMENT (July 21st, 1997)
Commonwealth Biotechnologies Inc – EMPLOYMENT AGREEMENT (July 21st, 1997)
Commonwealth Biotechnologies Inc – EMPLOYMENT AGREEMENT (July 21st, 1997)
Commonwealth Biotechnologies Inc – WARRANT AGREEMENT (July 21st, 1997)